Head and neck cancer and occupational exposure to leather dust: results from the ICARE study, a French case-control study.


Journal

Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645

Informations de publication

Date de publication:
29 03 2019
Historique:
received: 19 10 2018
accepted: 20 03 2019
entrez: 30 3 2019
pubmed: 30 3 2019
medline: 9 5 2019
Statut: epublish

Résumé

Leather dust is an established carcinogen of the sinonasal cavities; however, evidence is lacking regarding its association with other head and neck cancers (HNC). To date, few studies have been conducted on the association between occupational leather dust exposure and the risk of oral, pharyngeal, and laryngeal cancers. The objective of this study was to investigate the association between the risk of HNC and occupational exposure to leather dust. Lifestyle habits and occupational history were collected for 2161 patients with squamous cell carcinoma of oral cavity, pharynx, and larynx, and 3555 controls, using a standardized questionnaire. Occupational exposure to leather dust was assessed using a job-exposure matrix. Odds ratios (OR) and 95% confidence intervals (CI) for HNC globally and by subsite were estimated using multivariate unconditional, and polytomous logistic regressions, respectively. Cumulative lifetime exposure to leather dust < 6 mg/m Our study did not provide enough evidence for an increased risk of HNC related to occupational exposure to leather dust. Further studies are needed to understand the risks of specific tasks in the leather industry.

Sections du résumé

BACKGROUND
Leather dust is an established carcinogen of the sinonasal cavities; however, evidence is lacking regarding its association with other head and neck cancers (HNC). To date, few studies have been conducted on the association between occupational leather dust exposure and the risk of oral, pharyngeal, and laryngeal cancers. The objective of this study was to investigate the association between the risk of HNC and occupational exposure to leather dust.
METHODS
Lifestyle habits and occupational history were collected for 2161 patients with squamous cell carcinoma of oral cavity, pharynx, and larynx, and 3555 controls, using a standardized questionnaire. Occupational exposure to leather dust was assessed using a job-exposure matrix. Odds ratios (OR) and 95% confidence intervals (CI) for HNC globally and by subsite were estimated using multivariate unconditional, and polytomous logistic regressions, respectively.
RESULTS
Cumulative lifetime exposure to leather dust < 6 mg/m
CONCLUSION
Our study did not provide enough evidence for an increased risk of HNC related to occupational exposure to leather dust. Further studies are needed to understand the risks of specific tasks in the leather industry.

Identifiants

pubmed: 30922305
doi: 10.1186/s12940-019-0469-3
pii: 10.1186/s12940-019-0469-3
pmc: PMC6440008
doi:

Substances chimiques

Air Pollutants, Occupational 0
Carcinogens 0
Dust 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

27

Investigateurs

Anne-Valérie Guizard (AV)
Arlette Danzon (A)
Anne-Sophie Woronoff (AS)
Michel Velten (M)
Antoine Buemi (A)
Émilie Marrer (É)
Brigitte Trétarre (B)
Marc Colonna (M)
Patricia Delafosse (P)
Paolo Bercelli (P)
Florence Molinié (F)
Simona Bara (S)
Bénédicte Lapotre-Ledoux (B)
Nicole Raverdy (N)
Sylvie Cénée (S)
Oumar Gaye (O)
Florence Guida (F)
Farida Lamkarkach (F)
Loredana Radoï (L)
Marie Sanchez (M)
Isabelle Stücker (I)
Matthieu Carton (M)
Diane Cyr (D)
Annie Schmaus (A)
Joëlle Févotte (J)
Corinne Pilorget (C)
Gwenn Menvielle (G)
Danièle Luce (D)

Références

Cancer Causes Control. 2012 Jan;23(1):69-88
pubmed: 22037906
Arch Environ Health. 1979 Jan-Feb;34(1):33-7
pubmed: 434924
Am J Ind Med. 1984;5(4):303-14
pubmed: 6720693
Scand J Work Environ Health. 1999;25 Suppl 2:1-116
pubmed: 10507118
IARC Monogr Eval Carcinog Risks Hum. 2010;96:3-1383
pubmed: 21735939
Chem Biol Interact. 2001 Jun 1;135-136:487-503
pubmed: 11397408
Am J Ind Med. 1991;20(4):477-93
pubmed: 1785612
BMC Public Health. 2011 Dec 14;11:928
pubmed: 22171573
Occup Environ Med. 1998 Jun;55(6):393-400
pubmed: 9764099
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1-441
pubmed: 23189750
Int J Occup Environ Health. 2002 Oct-Dec;8(4):320-7
pubmed: 12412849
Am J Ind Med. 2006 Jul;49(7):535-46
pubmed: 16732556
Cancer Causes Control. 2003 Apr;14(3):203-12
pubmed: 12814199
Scand J Work Environ Health. 1993 Apr;19(2):89-95
pubmed: 8316784
Ann Occup Hyg. 2011 Oct;55(8):865-78
pubmed: 21926066
Am J Epidemiol. 1990 Oct;132(4):746-8
pubmed: 2403115
Occup Environ Med. 2006 Nov;63(11):726-33
pubmed: 16601013
Am J Ind Med. 1983;4(4):523-32
pubmed: 6869377
Int J Cancer. 2008 Aug 1;123(3):653-9
pubmed: 18470913
Prev Med. 2011 Oct;53 Suppl 1:S5-S11
pubmed: 21962471
IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438
pubmed: 15285078
Int Arch Occup Environ Health. 2012 May;85(4):341-51
pubmed: 21785866
Cancer Med. 2013 Dec;2(6):978-86
pubmed: 24403272
Am J Ind Med. 1987;12(5):615-23
pubmed: 3687954
Int J Epidemiol. 2004 Aug;33(4):799-806
pubmed: 15155704
Br J Ind Med. 1986 May;43(5):332-8
pubmed: 3707871
IARC Monogr Eval Carcinog Risks Hum. 1992;54:1-310
pubmed: 1345371
Am J Epidemiol. 2007 Nov 15;166(10):1159-73
pubmed: 17761691
Eur J Cancer. 2010 Feb;46(3):588-98
pubmed: 19857956
Lancet Oncol. 2009 May;10(5):453-4
pubmed: 19418618
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt C):11-465
pubmed: 23189751
Occup Environ Med. 1996 Jun;53(6):394-8
pubmed: 8758034
Int J Cancer. 2008 Jun 15;122(12):2811-9
pubmed: 18351646
Occup Environ Med. 2000 Nov;57(11):767-73
pubmed: 11024201
J Occup Environ Med. 2012 Jan;54(1):71-84
pubmed: 22157731

Auteurs

Loredana Radoï (L)

Paris Sud, Paris Saclay University, UVSQ, CESP, INSERM U1018, Environmental Epidemiology of Cancer Team, Villejuif, France. loredana.radoi@inserm.fr.
Oral medicine and oral surgery department, University Paris Descartes, Faculty of Dental surgery, Paris, France. loredana.radoi@inserm.fr.

Fatoumata Sylla (F)

Paris Sud, Paris Saclay University, UVSQ, CESP, INSERM U1018, Environmental Epidemiology of Cancer Team, Villejuif, France.
University Pierre et Marie Curie, Paris, France.

Mireille Matrat (M)

Paris Sud, Paris Saclay University, UVSQ, CESP, INSERM U1018, Environmental Epidemiology of Cancer Team, Villejuif, France.
Faculty of Medicine, University Paris Est Créteil, Créteil, France.
Centre Hospitalier Intercommunal, Service des Pathologies Professionnelles et de l'Environnement, Créteil, France.

Christine Barul (C)

Université de Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, Pointe-à-Pitre, France.

Gwenn Menvielle (G)

Department of social epidemiology, INSERM, Sorbonne Université, Institut Pierre Louis d'Epidémiologie et de Santé Publique IPLESP, Paris, France.

Patricia Delafosse (P)

Isère Cancer Registry, CHU Grenoble-Alpes, Grenoble; FRANCIM Network, Toulouse, France.

Isabelle Stücker (I)

Paris Sud, Paris Saclay University, UVSQ, CESP, INSERM U1018, Environmental Epidemiology of Cancer Team, Villejuif, France.

Danièle Luce (D)

Université de Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail)-UMR_S 1085, Pointe-à-Pitre, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH